-
ProQR Therapeutics (NASDAQ:PRQR) Given Average Rating of "Buy" by Analysts
Source: Buzz FX / 06 Jan 2025 05:06:16 America/New_York
ProQR Therapeutics (NASDAQ:PRQR) Given Average Rating of "Buy" by Analysts Written by MarketBeat January 6, 2025 Share Link copied to clipboard. ProQR Therapeutics ( NASDAQ:PRQR - Get Free Report ) has been given an average rating of "Buy"
Read more...